U.S. Markets open in 1 min.

NanoViricides, Inc. (NNVC)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.270.00 (0.00%)
At close: 3:59PM EDT
People also watch
BTXISCOGALTAVXLECTE

NanoViricides, Inc.

1 Controls Drive
Shelton, CT 06484
United States
203-937-6137
http://www.nanoviricides.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees7

Key Executives

NameTitlePayExercisedAge
Dr. Anil R. Diwan Ph.D.Chairman, Pres and Sec.420.83kN/A58
Dr. Eugene Seymour M.D., MPHChief Exec. Officer and Director420.83kN/A76
Ms. Meeta R. Vyas SB, MBAChief Financial Officer129.6kN/A58
Dr. Randall W. Barton Ph.D.Chief Scientific Officer and Chief Regulatory OfficerN/AN/A70
Dr. Jayant Tatake Ph.D.VP of R&DN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs comprising NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for novel strain of H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; and HIVCide, an anti-human immunodeficiency virus (HIV) drug candidate that could enable a functional cure for HIV/AIDS. It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes lesions; anti-viral eye drops against external eye viral infections; and other research programs against Rabies virus, Ebola, and Marburg viruses. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.

Corporate Governance

NanoViricides, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.